Hydroxyapatite deposition disease (HADD) involving two or more anatomically distinct joint sites simultaneously, classified under the crystal arthropathy family of diagnoses.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 9
- Region
- Multi-region
Documentation tips
What should appear in the chart to support M11.09.
Source · Editorial brief grounded in 5 cited references ↓
- List every affected joint by name and side — 'bilateral shoulders and right hip' is sufficient to support M11.09; 'multiple joints' alone is not.
- Specify the crystal type as hydroxyapatite (not simply 'calcific tendinitis' or 'crystal arthropathy') to justify M11.0x over M11.8x or M11.9.
- Record imaging findings — radiographic calcification, ultrasound echogenic foci, or MRI signal changes — at each affected site to substantiate multi-site involvement.
- Note symptom duration and acuity (acute flare vs. chronic) at each site; this supports medical necessity for procedures performed at multiple joints on the same date.
- If a systemic or metabolic condition is suspected or confirmed as the etiology of HADD, document and code it additionally.
Related CPT procedures
Procedure codes commonly billed with M11.09. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M11.09 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Using M11.09 when only one joint is affected — 'multiple sites' requires documentation of two or more anatomically distinct regions; otherwise use the single-site code.
- Conflating HADD with CPPD: chondrocalcinosis codes (M11.1x, M11.2x) apply to calcium pyrophosphate crystals, not hydroxyapatite — the crystal type must be explicitly documented or inferable.
- Defaulting to M11.9 (Crystal arthropathy, unspecified) when the crystal type is documented as hydroxyapatite — M11.09 is more specific and should be used.
- Assigning M11.00 (unspecified site) when multiple sites are documented — M11.09 is the correct code for confirmed polyarticular involvement.
- Failing to add a secondary code for an underlying metabolic condition (e.g., hyperparathyroidism E21.x, renal osteodystrophy N25.0) when the provider links HADD to a systemic cause.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M11.09 is the correct billable code when a provider documents hydroxyapatite deposition disease affecting multiple joints — for example, bilateral shoulders plus the hip, or the shoulder and knee together. The 'multiple sites' designation is not a shortcut for unspecified laterality; it applies only when two or more distinct anatomical regions are genuinely involved and documented. If involvement is limited to a single joint region, use the site-specific code (e.g., M11.011 for right shoulder, M11.061 for right knee).
HADD occurs when calcium hydroxyapatite crystals deposit in periarticular soft tissues, tendons, or the joint itself, triggering an acute or chronic inflammatory response. The shoulder is the most commonly affected single site, but polyarticular presentations do occur. M11.09 sits within the M11.0 parent category (Hydroxyapatite deposition disease), which is distinct from chondrocalcinosis (M11.1–M11.2) and other specified crystal arthropathies (M11.8–). Do not conflate HADD with CPPD (calcium pyrophosphate deposition disease) — they are separate crystal arthropathies with separate code families.
For payers, M11.09 may support authorization for imaging (plain radiographs, ultrasound, or MRI to confirm calcific deposits at multiple sites), aspiration, corticosteroid injection, needling/barbotage, or extracorporeal shock wave therapy depending on payer policy. When a secondary metabolic condition (e.g., hyperparathyroidism, renal failure) is the underlying cause of crystal deposition, code that condition additionally per ICD-10-CM convention.
Sibling codes
Other billable codes under M11.0 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01When does HADD at two shoulders qualify for M11.09 vs. two separate laterality codes?
02Can M11.09 be used if the provider documents 'calcific tendinitis at multiple sites'?
03What distinguishes M11.09 from M11.89 (Other specified crystal arthropathies, multiple sites)?
04Is a biopsy or aspiration required to code HADD, or can imaging alone support it?
05Should a secondary code be added when HADD is linked to end-stage renal disease or hyperparathyroidism?
06Does M11.09 require a 7th-character extension?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M11-/M11.09
- 03icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M11-/M11.0
- 04aapc.comhttps://www.aapc.com/codes/icd-10-codes/M11.0
- 05icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M11-
Mira AI Scribe
Mira AI Scribe captures the names and laterality of every symptomatic joint, imaging confirmation of calcific deposits at each site, crystal type (hydroxyapatite), and any associated metabolic diagnosis from the encounter note. This prevents collapse to the less-specific M11.00 (unspecified site) or M11.9 (unspecified crystal arthropathy), which can trigger payer downcoding or medical necessity denials for multi-joint procedures.
See how Mira captures M11.09 documentation